phosphoinositide-dependent kinase 1 inhibitors (University of Rochester)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namephosphoinositide-dependent kinase 1 inhibitors (University of Rochester)
Drug Alias NamePDK-1 inhibitors (University of Rochester)KP-372
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action3-phosphoinositide-dependent protein kinase 1 inhibitors
Targets3-phosphoinositide-dependent protein kinase 1
Therapy Area/IndicationsMycoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Rochester
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Rochester
Active IndicationsN/A
Inactive IndicationsMycoses

Other Information

ATC CodeN/A
Related LinksN/A